SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?


To: Jeffrey S. Mitchell who wrote (2154)7/26/1998 1:50:00 AM
From: Cavalry  Read Replies (3) | Respond to of 4028
 
YOUR PROFILE SAYS FBNA, NICE TRY BASHER
CAV WAMM#1



To: Jeffrey S. Mitchell who wrote (2154)7/26/1998 3:19:00 AM
From: Graystone  Respond to of 4028
 
Evil Hypester
or
Leaving out the Shrimp

Excellent post, delineate's the major product line (whatever is fashionable) but I don't think you have given enough thought to how many shrimps there are in the Antarctic, or how many people live in China. After all, look at MSFT, they were a penny stock once. It is entirely possible this company could do well, look at IBM or CISCO.
If you think that a cure for cancer won't be a good revenue stream, you are wrong. Buy shares or you will likely die when you are refused treatment in Costa Rico at the Shirpa clinic.

This is such big news, you don't get it, look at GERN's website. Do your D&D, phone Dell collect at 713-780-1399,this is D&D, not that pitiful array of facts. Have you been out to lunch yet. I spent $3,000 dollars to go down there and kiss Skillerns ass, now that I have put everything I own in the stock, I would appreciate it if you would just take your facts and leave.

GO CYGS GO TO .....



To: Jeffrey S. Mitchell who wrote (2154)7/26/1998 2:31:00 PM
From: Mr. Forthright  Respond to of 4028
 
<<It costs millions, if not tens of millions of dollars to go from animal research to human clinicals, from phase I to phase III to getting FDA approval to developing and marketing and selling a product, not to mention years of painstaking research.>>

$359 million on average and 12 years on average to get from pre-clinical studies to FDA approval.